Drug demonstrates poor efficacy in advanced bladder cancer
An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial published in The Lancet Oncology.
Apr 30, 2021
0
38
An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial published in The Lancet Oncology.
Apr 30, 2021
0
38
A large team of researchers with members from the U.K., Canada, Uganda and Zimbabwe has found that the common antibiotic cotrimoxazole reduces adverse health events in children with HIV. In their paper published in the journal ...
More than 8 million pounds of bisphenol A (BPA) is produced each year and reaches 90 percent of the population through consumer and medical products. Epidemiological studies find BPA exposure in adults correlate with adverse ...
May 14, 2018
2
86
A study led by Massachusetts General Hospital (MGH) and Icahn School of Medicine at Mount Sinai (ISSMS) investigators has linked, for the first time in humans, activity in a stress-sensitive structure within the brain to ...
Jan 11, 2017
0
533
(Medical Xpress)—Science has shown that children who experience stressful events are more likely to face poor health outcomes as adults, but new research shows the effects may show up much sooner—in fact, almost immediately.
Mar 12, 2014
0
0
Genomic research is widely expected to transform medicine, but progress has been slower than expected. While critics argue that the genomics "promise" has been broken – and that money might be better spent elsewhere—proponents ...
Jan 4, 2013
0
0
(HealthDay) -- A supplement mixture (Souvenaid) containing dietary precursors and specific nutrients can improve memory in drug-naive patients with mild Alzheimer's disease (AD), according to a study published in the July ...
Jul 12, 2012
1
0
The first-ever trial using human embryonic stem cells to treat paralysis has been halted due to high costs and the company will focus instead on new cancer treatments, Geron said Tuesday.
Nov 15, 2011
2
0
The U.S. Supreme Court will take up a case Tuesday that could impact how women get access to mifepristone, one of the two pills used in the most common type of abortion in the nation.
Mar 24, 2024
0
0
A recent Mayo Clinic study examining the effects of daylight saving time (DST) on heart health suggests that the impact is likely minimal.
Feb 27, 2024
0
0